1. A Multicenter Phase II Study of Second‐Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy. (9th April 2020) Authors: Lin, Zhong‐Zhe; Chen, Bang‐Bin; Hung, Yi‐Ping; Huang, Po‐Hsiang; Shen, Ying‐Chun; Shao, Yu‐Yun; Hsu, Chih‐Hung; Cheng, Ann‐Lii; Lee, Rheun‐Chuan; Chao, Yee; Hsu, Chiun Journal: Oncologist Issue: Volume 25:Number 9(2020) Page Start: e1280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti‐angiogenic therapy. (28th May 2013) Authors: Shao, Yu‐Yun; Liang, Po‐Chin; Wu, Yao‐Ming; Huang, Chun‐Chieh; Huang, Kai‐Wen; Cheng, Jason C.; Hsu, Chih‐Hung; Hsu, Chiun; Cheng, Ann‐Lii; Lin, Zhong‐Zhe Journal: Liver international Issue: Volume 33:Number 9(2013:Oct.) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations. Issue 11 (5th January 2019) Authors: Lin, Yen‐Ting; Chen, Jin‐Shing; Liao, Wei‐Yu; Ho, Chao‐Chi; Hsu, Chia‐Lin; Yang, Ching‐Yao; Chen, Kuan‐Yu; Lee, Jih‐Hsiang; Lin, Zhong‐Zhe; Shih, Jin‐Yuan; Yang, James Chih‐Hsin; Yu, Chong‐Jen Journal: International journal of cancer Issue: Volume 144:Issue 11(2019) Page Start: 2887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma. (31st August 2019) Authors: Shao, Yu‐Yun; Liu, Tsung‐Hao; Hsu, Chiun; Lu, Li‐Chun; Shen, Yin‐Chung; Lin, Zhong‐Zhe; Cheng, Ann‐Lii; Hsu, Chih‐Hung Journal: Liver international Issue: Volume 39:Number 11(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma. Issue 6 (4th December 2012) Authors: Lu, Li‐Chun; Shao, Yu‐Yun; Kuo, Raymond N. C.; Lin, Zhong‐Zhe; Yeh, Yi‐Chun; Shau, Wen‐Yi; Hsu, Chih‐Hung; Cheng, Ann‐Lii; Lai, Mei‐Shu Journal: Cancer Issue: Volume 119:Issue 6(2013) Page Start: 1210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Klotho‐beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma. (11th July 2019) Authors: Lin, Zhong‐Zhe; Hsu, Chiun; Jeng, Yung‐Ming; Hu, Fu‐Chang; Pan, Hung‐Wei; Wu, Yao‐Ming; Hsu, Hey‐Chi; Cheng, Ann‐Lii Journal: Liver international Issue: Volume 39:Number 9(2019) Page Start: 1682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Potential synergistic anti‐tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma. Issue 12 (18th November 2014) Authors: Ou, Da‐Liang; Chang, Chun‐Jung; Jeng, Yung‐Ming; Lin, Yi‐Jang; Lin, Zhong‐Zhe; Gandhi, Anita K; Liao, Sheng‐Chieh; Huang, Zi‐Ming; Hsu, Chiun; Cheng, Ann‐Lii Journal: Journal of gastroenterology and hepatology Issue: Volume 29:Issue 12(2014:Dec.) Page Start: 2021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption. Issue 2 (10th January 2014) Authors: Lin, Zhong‐Zhe; Chou, Chia‐Hung; Cheng, Ann‐Lii; Liu, Wei‐Lin; Chia‐Hsien Cheng, Jason Journal: International journal of cancer Issue: Volume 135:Issue 2(2014:Jul. 15) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real‐World Data on Prognostic Factors for Overall Survival in EGFR Mutation‐Positive Advanced Non‐Small Cell Lung Cancer Patients Treated with First‐Line Gefitinib. (15th May 2017) Authors: Yao, Zong‐Han; Liao, Wei‐Yu; Ho, Chao‐Chi; Chen, Kuan‐Yu; Shih, Jin‐Yuan; Chen, Jin‐Shing; Lin, Zhong‐Zhe; Lin, Chia‐Chi; Chih‐Hsin Yang, James; Yu, Chong‐Jen Journal: Oncologist Issue: Volume 22:Number 9(2017) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real‐World Data on Prognostic Factors for Overall Survival in EGFR Mutation‐Positive Advanced Non‐Small Cell Lung Cancer Patients Treated with First‐Line Gefitinib. (September 2017) Authors: Yao, Zong‐Han; Liao, Wei‐Yu; Ho, Chao‐Chi; Chen, Kuan‐Yu; Shih, Jin‐Yuan; Chen, Jin‐Shing; Lin, Zhong‐Zhe; Lin, Chia‐Chi; Chih‐Hsin Yang, James; Yu, Chong‐Jen Journal: Oncologist Issue: Volume 22:Number 9(2017) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗